Natural Capsules [NATCAPSUQ] vs Sun Pharma Advanced [SPARC] Detailed Stock Comparison

Natural Capsules Ltd.

NSE
Loading...

Sun Pharma Advanced Research Company Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 18 vital metrics comparison: Natural Capsules Ltd. wins in 13 metrics, Sun Pharma Advanced Research Company Ltd. wins in 5 metrics, with 0 ties. Natural Capsules Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Natural Capsules Ltd. Sun Pharma Advanced Research Company Ltd. Better
P/E Ratio (TTM) 337.98 -13.65 Natural Capsules Ltd.
Price-to-Book Ratio 0.71 -13.55 Natural Capsules Ltd.
Debt-to-Equity Ratio 45.69 -1.21 Natural Capsules Ltd.
PEG Ratio -0.05 -11.15 Natural Capsules Ltd.
EV/EBITDA -63.36 -22.27 Sun Pharma Advanced Research Company Ltd.
Profit Margin (TTM) -11.03% -53.22% Natural Capsules Ltd.
Operating Margin (TTM) -17.72% -700.71% Natural Capsules Ltd.
Return on Equity 0.24% 157.88% Sun Pharma Advanced Research Company Ltd.
Return on Assets (TTM) 0.15% -102.08% Natural Capsules Ltd.
Free Cash Flow (TTM) $-178.78M $-3.71B Natural Capsules Ltd.
1-Year Return -25.96% 14.56% Sun Pharma Advanced Research Company Ltd.
Price-to-Sales Ratio (TTM) 0.93 87.98 Natural Capsules Ltd.
Enterprise Value $2.87B $50.87B Sun Pharma Advanced Research Company Ltd.
EV/Revenue Ratio 1.65 95.73 Natural Capsules Ltd.
Gross Profit Margin (TTM) 49.74% -59.53% Natural Capsules Ltd.
Revenue per Share (TTM) $182 $2 Natural Capsules Ltd.
Earnings per Share (Diluted) $-18.51 $-8.25 Sun Pharma Advanced Research Company Ltd.
Beta (Stock Volatility) -0.17 0.19 Natural Capsules Ltd.

Natural Capsules Ltd. vs Sun Pharma Advanced Research Company Ltd. Stock Performance Analysis

Loading Price Chart...

NATCAPSUQ
SPARC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Natural Capsules Ltd.-0.75%-6.82%1.83%4.47%-15.93%-13.52%
Sun Pharma Advanced Research Company Ltd.2.14%-5.81%49.25%68.87%37.58%54.41%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Natural Capsules Ltd.-25.96%-34.83%-34.83%-34.83%-34.83%-34.83%
Sun Pharma Advanced Research Company Ltd.14.56%13.10%-5.14%-23.02%148.11%-27.03%

Performance & Financial Health Analysis: Natural Capsules Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricNATCAPSUQSPARC
Market Information
Market Cap i₹1.63B₹46.75B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i9,1712,401,062
90 Day Avg. Volume i9,2072,083,443
Last Close₹155.35₹212.97
52 Week Range₹136.36 - ₹296.00₹108.00 - ₹248.75
% from 52W High-47.52%-14.38%
All-Time High₹296.00 (Sep 26, 2025)₹875.00 (Apr 24, 2006)
% from All-Time High-47.52%-75.66%
Growth Metrics
Quarterly Revenue Growth-0.14%-0.43%
Quarterly Earnings Growth-0.14%-0.43%
Financial Health
Profit Margin (TTM) i-0.11%-0.53%
Operating Margin (TTM) i-0.18%-7.01%
Return on Equity (TTM) i0.00%1.58%
Debt to Equity (MRQ) i45.69-1.21
Cash & Liquidity
Book Value per Share (MRQ)₹219.30₹-10.63
Cash per Share (MRQ)₹5.20₹0.03
Operating Cash Flow (TTM) i₹103.85M₹-3,484,287,000
Levered Free Cash Flow (TTM) i₹6.17M₹-3,425,094,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Natural Capsules Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricNATCAPSUQ (Apr 24, 2026)SPARC (Apr 22, 2026)
Price Ratios
P/E Ratio (TTM) i337.98-13.65
Forward P/E iN/A2.60
PEG Ratio i-0.05-11.15
Price to Sales (TTM) i0.9387.98
Price to Book (MRQ) i0.71-13.55
Market Capitalization
Market Capitalization i₹1.63B₹46.75B
Enterprise Value i₹2.87B₹50.87B
Enterprise Value Metrics
Enterprise to Revenue i1.6595.73
Enterprise to EBITDA i-63.36-22.27
Risk & Other Metrics
Beta i-0.170.19
Book Value per Share (MRQ) i₹219.30₹-10.63

Financial Statements Comparison: Natural Capsules Ltd. vs Sun Pharma Advanced Research Company Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricNATCAPSUQ (2025)SPARC (2025)
Revenue/Sales i1.64B717.66M
Cost of Goods Sold i884.26M1.10B
COGS % of Revenue i53.9%153.2%
Gross Profit i757.25M-381.94M
Gross Margin i46.1%-53.2%
Research & Development i15.99MN/A
Operating Income (EBIT) i90.26M-3.34B
Operating Margin i5.5%-465.5%
EBITDA i187.43M-3.23B
EBITDA Margin i11.4%-450.0%
Pre-Tax Income i27.91M-3.43B
Pre-Tax Income % of Revenue i1.7%-477.6%
Income Tax i21.74M-2.72M
Income Tax % of Revenue i1.3%-0.4%
Net Income (Profit) i6.17M-3.43B
Profit Margin i0.4%-477.3%

Balance Sheet & Liquidity Metrics

MetricNATCAPSUQ (2025)SPARC (2025)
Cash & Equivalents i6.63M19.64M
Total Current Assets i1.30B261.97M
Total Current Assets % of Revenue i78.9%36.5%
Total Current Liabilities i999.93M3.74B
Total Current Liabilities % of Revenue i60.9%521.5%
Long-Term Debt i574.25M1.07B
Long-Term Debt % of Revenue i35.0%149.0%
Total Shareholders Equity i2.57B-2.17B
Retained Earnings i794.95M-23.22B
Retained Earnings % of Revenue i48.4%-3,235.0%
Property, Plant & Equipment i31.20M178.02M

Cash Flow Statement Comparison

MetricNATCAPSUQ (2025)SPARC (2025)
Operating Cash Flow i103.85M-3.48B
Operating Cash Flow % of Revenue i6.3%-485.5%
Capital Expenditures i-446.30M-97.45M
Free Cash Flow i-178.78M-3.71B
FCF Margin i-10.9%-516.4%
Debt Repayment i-51.89M-3.69B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricNATCAPSUQSPARC
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.39M324.52M
Float Shares i3.57M91.32M
% Held by Insiders i65.52%72.96%
% Held by Institutions i0.00%2.56%
% Held by Public i34.48%24.48%

Dividend Analysis & Yield Comparison: Natural Capsules Ltd. vs Sun Pharma Advanced Research Company Ltd.

MetricNATCAPSUQSPARC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A